Opus Genetics, Inc. Operating Loss Carryforwards
Opus Genetics, Inc. (IRD) had Operating Loss Carryforwards of $31.50 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-03-12
- 2025-12-31: Operating Loss Carryforwards $31.50M.
- 2024-12-31: Operating Loss Carryforwards $17.10M.
- 2023-12-31: Operating Loss Carryforwards $10.60M.
- 2022-12-31: Operating Loss Carryforwards $10.90M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $31.50M 10-K · filed 2026-03-12 |
| 2024-12-31 | $17.10M 10-K · filed 2026-03-12 |
| 2023-12-31 | $10.60M 10-K · filed 2025-03-31 |
| 2022-12-31 | $10.90M 10-K · filed 2024-03-08 |
| 2021-12-31 | $15.70M 10-K · filed 2023-03-30 |
| 2020-09-30 | $161.86M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $160.15M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $157.96M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $156.59M 10-Q · filed 2020-10-29 |
| 2019-09-30 | $154.53M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $152.42M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $151.07M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $147.09M 10-K · filed 2020-02-21 |
| 2018-09-30 | $142.49M 10-Q · filed 2018-11-02 |
| 2018-06-30 | $138.36M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $133.91M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $127.88M 10-K · filed 2019-03-07 |
| 2017-09-30 | $123.52M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $119.62M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $115.75M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $111.61M 10-K · filed 2018-03-09 |
| 2016-09-30 | $110.48M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $107.10M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $103.59M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $98.95M 10-K · filed 2017-02-24 |
| 2015-09-30 | $95.01M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $90.50M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $86.07M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $81.62M 10-K · filed 2016-03-14 |
| 2014-09-30 | $78.05M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $74.75M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $71.70M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $69.04M 10-K · filed 2015-03-16 |
| 2013-09-30 | $66.91M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $65.09M 10-Q · filed 2013-08-12 |
| 2013-03-31 | $63.28M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $61.78M 10-K · filed 2014-03-21 |
| 2012-09-30 | $60.70M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $58.97M 10-Q · filed 2012-08-08 |
| 2011-12-31 | $55.39M 10-K · filed 2013-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |